Open Beta
TREN
MetriLume
TREN

US marketsSNOA

SEC-sourced researchBeta

SNOA

Sonoma Pharmaceuticals, Inc.

Company comparison ↗

Data passport

CIK
0001367083
Exchange
Nasdaq
Business activity
— · SIC 3841
Financial inputs
6/6
Filing date
Oct 6, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: March 2025: 14,288,000.0000 USD; March 2026: 19,529,000.0000 USD19.5M USD0 USD0March 2025March 2026
SNOA · Exact amounts and source periods · USD
Period endRevenueFiling date
March 202514,288,000.0000Jun 16, 2026
March 202619,529,000.0000Jun 16, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
March 202619,529,000.0000-3,175,000.0000-3,933,000.000013,960,000.000010,865,000.0000Jun 16, 2026
March 202514,288,000.0000-3,457,000.0000-88,000.000013,693,000.00009,282,000.0000Jun 16, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$19.53MMarch 2026Jun 16, 202610-K
Previous period revenueRevenues$14.29MMarch 2025Jun 16, 202610-K
Net incomeNetIncomeLoss-$3.18MMarch 2026Jun 16, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$3.93MMarch 2026Jun 16, 202610-K
Total assetsAssets$13.96MMarch 2026Jun 16, 202610-K
Total liabilitiesLiabilities$10.87MMarch 2026Jun 16, 202610-K

New filings

Explore methodology ↗